Financial calendar

The key dates in our financial year

Investor Briefing

March 12, 2026 
09:30 - 2.00pm GMT

dsm-firmenich will host an Investor Briefing for institutional investors and equity analysts where senior management will update the market on our plans as a fully focused consumer company.

Date: 12th March 2026
Time: 9.30am - 2.00pm GMT
Location: Sofitel St. James - London

During the event, we will provide deeper insights into:

  • Our strategic roadmap and key growth initiatives
  • Operational performance and efficiency programs
  • Business unit updates, focusing on their innovation-driven growth initiatives

The program will include presentations from Dimitri de Vreeze, Chief Executive Officer, Ralf Schmeitz, Chief Financial Officer and the leaders of the three Business Units:

Emmanuel Butstraen – Perfumery & Beauty
Maurizio Clementi – Taste, Texture & Health
Alessandre Keller – Health, Nutrition & Care

Participants will have the opportunity to meet and engage with management.

We have 50 places available and will prioritize allocation of these places to institutional shareholders and analysts on a first come first served basis.

Registration:
Please contact Sandra Segers if you would like to participate.

Webcast:
A live webcast will be available for those unable to attend in person. Replay details will be shared on our Investor Relations website.

Investor Briefing

March 12, 2026 
09:30 - 2.00pm GMT

dsm-firmenich will host an Investor Briefing for institutional investors and equity analysts where senior management will update the market on our plans as a fully focused consumer company.

Date: 12th March 2026
Time: 9.30am - 2.00pm GMT
Location: Sofitel St. James - London

During the event, we will provide deeper insights into:

  • Our strategic roadmap and key growth initiatives
  • Operational performance and efficiency programs
  • Business unit updates, focusing on their innovation-driven growth initiatives

The program will include presentations from Dimitri de Vreeze, Chief Executive Officer, Ralf Schmeitz, Chief Financial Officer and the leaders of the three Business Units:

Emmanuel Butstraen – Perfumery & Beauty
Maurizio Clementi – Taste, Texture & Health
Alessandre Keller – Health, Nutrition & Care

Participants will have the opportunity to meet and engage with management.

We have 50 places available and will prioritize allocation of these places to institutional shareholders and analysts on a first come first served basis.

Registration:
Please contact Sandra Segers if you would like to participate.

Webcast:
A live webcast will be available via this link. Replay details will be shared on our Investor Relations website.

Annual General Meeting 2026

May 7, 2026
10:30am CEST

The Annual General Meeting of Shareholders of DSM-Firmenich AG 2026 will be held on Thursday 7 May 2026 at our head office at Wurmisweg 576, 4303 Kaiseraugst, Aargau, Switzerland, at 10.30 CEST ("AGM 2026").

Investor Briefing
March 12, 2026
Q1 2026 trading update
May 6, 2026
Annual General Meeting 2026
May 7, 2026
Q3 2026 trading update
November 4, 2026
H1 2026 results
July 30, 2026
Full year 2025 results
February 12, 2026
Q3 2025 results
October 30, 2025
H1 2025 results
July 31, 2025
Q1 2025 results
April 30, 2025
ESG Investor Event
March 25, 2025
Full Year 2024 Results
February 13, 2025

Stay informed

Our alert service delivers the latest press releases, stories and regulatory news directly to your mailbox.

Contact Investor Relations

Whether you’re a shareholder, potential shareholder, or analyst, our Investor relations team is on hand to answer your questions.

Explore more

  • Financial results & presentations

    All the key financial performance information published dsm-firmenich

  • News

    Read more about news from dsm-firmenich and its businesses

  • Investors

    Two global leaders in science and innovation have joined forces to become dsm-firmenich, creating a world of potential for investors.

Stay up to date

Be the first to know about key news as we continue shaping the future and bringing progress to life.

번역 면책 조항 이 페이지는 AI를 사용하여 자동 번역되었습니다. 정확성을 목표로 하지만, 번역이 완벽하지 않거나 원본 내용을 잘못 해석할 수 있습니다. 중요한 정보는 원본 언어 버전을 참조해 주시기 바랍니다. AI 번역은 사용자의 재량에 따라 사용하시기 바랍니다. DSM‑Firmenich는 이러한 번역으로 인해 발생하는 오류나 오해에 대해 책임을 지지 않습니다.